ICMR’s anti-malaria vaccine still 6-7 years away

ICMR seeks tech transfer for its anti-malaria vaccine, AdFalciVax, likely taking 6-7 years for readiness, targeting severe malaria caused by P. falciparum.

ICMR’s anti-malaria vaccine still 6-7 years away
ICMR seeks tech transfer for its anti-malaria vaccine, AdFalciVax, likely taking 6-7 years for readiness, targeting severe malaria caused by P. falciparum.